10 results
10-Q
2024 Q1
GUTS
Fractyl Health Inc.
13 May 24
Quarterly report
4:06pm
bodies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel
8-K
EX-99.1
GUTS
Fractyl Health Inc.
13 May 24
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
4:01pm
with the addition of Adrian Kimber as Chief Commercial Officer. We believe we have the resources and leadership in place to advance our portfolio
10-K
2023 FY
GUTS
Fractyl Health Inc.
1 Apr 24
Annual report
7:15am
progression and the lack of disease-modifying therapies.
Purpose-Built Leadership Team with Shared Mission to Advance Patient Care in Metabolic Disease … and for health systems. Our team aims to continuously advance and expand upon our body of knowledge in order to establish and maintain a scientific leadership
8-K
EX-99.1
GUTS
Fractyl Health Inc.
1 Apr 24
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:10am
Board of Directors. Mr. Conaway brings an extensive background in the commercialization of medical technologies and leadership in new product
424B4
GUTS
Fractyl Health Inc.
2 Feb 24
Prospectus supplement with pricing info
4:18pm
primarily by unchecked disease progression and the lack of disease-modifying therapies.
Purpose-Built Leadership Team with Shared Mission to Advance … a scientific leadership position in our therapeutic areas of focus. We do so by collaborating with expert advisors who are leaders in metabolic
S-1/A
aqdaj
29 Jan 24
IPO registration (amended)
6:09am
S-1
24lb63j3
14 Dec 23
IPO registration
3:39pm
S-1
EX-10.10
q48pyhicd0zj
14 Dec 23
IPO registration
3:39pm
DRS/A
f6g7rqqy 0x4n
21 Sep 23
Draft registration statement (amended)
12:00am
DRS/A
w8r1to10t
22 Aug 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next